These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33719816)

  • 21. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada.
    Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W
    BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S.
    Pelaez D; Weicker NP; Glick J; Mesenburg JV; Wilson A; Kirkpatrick H; Clouse E; Sherman SG
    AIDS Care; 2021; 33(sup1):1-10. PubMed ID: 33627006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic.
    Koren DE; Nichols JS; Simoncini GM
    AIDS Patient Care STDS; 2018 Dec; 32(12):490-494. PubMed ID: 30036080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK.
    Nakasone SE; Young I; Estcourt CS; Calliste J; Flowers P; Ridgway J; Shahmanesh M
    Sex Transm Infect; 2020 Aug; 96(5):349-354. PubMed ID: 32532928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.
    Dauria EF; Levine A; Hill SV; Tolou-Shams M; Christopoulos K
    Arch Sex Behav; 2021 May; 50(4):1743-1754. PubMed ID: 33236275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.
    Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS
    Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    Hirschhorn LR; Brown RN; Friedman EE; Greene GJ; Bender A; Christeller C; Bouris A; Johnson AK; Pickett J; Modali L; Ridgway JP
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):497-507. PubMed ID: 32692108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.
    Walters SM; Platt J; Anakaraonye A; Golub SA; Cunningham CO; Norton BL; Sevelius JM; Blackstock OJ
    AIDS Behav; 2021 Dec; 25(12):3987-3999. PubMed ID: 34138377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project.
    Blumenthal J; Landovitz R; Jain S; He F; Kofron R; Ellorin E; Ntim GM; Stockman JK; Corado K; Rivet Amico K; Moore DJ; Morris S
    AIDS Patient Care STDS; 2021 Dec; 35(12):481-487. PubMed ID: 34851726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.
    Glick JL; Russo R; Jivapong B; Rosman L; Pelaez D; Footer KHA; Sherman SG
    AIDS Behav; 2020 May; 24(5):1312-1333. PubMed ID: 31807973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Far More than Just a Prescription": Focus Groups With U.S. Family Planning Providers and Staff About Integrating PrEP for HIV Prevention Into Their Work.
    Razon N; Rodriguez A; Carlson K; Witt J; Logan R; Chambers B; Weber S; Seidman D
    Womens Health Issues; 2021; 31(3):294-300. PubMed ID: 33839000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an Electronic Algorithm for Identifying Cisgender Female Pre-Exposure Prophylaxis Candidates.
    Ridgway JP; Friedman EE; Bender A; Schmitt J; Cronin M; Brown RN; Johnson AK; Hirschhorn LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):5-8. PubMed ID: 33400588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.